<i>LYPD3</i>, a New Biomarker and Therapeutic Target for Acute Myelogenous Leukemia.

Hu, Tingting; Zhang, Yingjie; Yang, Tianqing; He, Qingnan; Zhao, Mingyi

LYPD3, a New Biomarker and Therapeutic Target for Acute Myelogenous Leukemia.

Hu, Tingting; Zhang, Yingjie; Yang, Tianqing; He, Qingnan; Zhao, Mingyi.

Afiliação

Hu T; Department of Pediatrics, Third Xiangya Hospital, Central South University, Changsha, China.
Zhang Y; College of Biology, Hunan University, Changsha, China.
Yang T; Department of Pediatrics, Third Xiangya Hospital, Central South University, Changsha, China.
He Q; Department of Pediatrics, Third Xiangya Hospital, Central South University, Changsha, China.
Zhao M; Department of Pediatrics, Third Xiangya Hospital, Central South University, Changsha, China.

Front Genet ; 13: 795820, 2022.

Article em En | MEDLINE | ID: mdl-35360840

Palavras-chave

COX; GSEA; LASSO; LYPD3; PI3K/AKT; acute myelogenous leukemia; p53; poor prognosis

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Genet Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google